Study on Beta Cell Preservation for Newly Diagnosed Ages 6-21

Discussion in 'General Discussion' started by Jeff, Apr 11, 2017.

  1. Jeff

    Jeff Founder, CWD

    Jun 1, 1995
    A new study is underway to investigate a drug to preserve beta cell function in newly diagnosed people ages 6-21.

    The study is called T1GER.

    From their web site:

    The purpose of the T1GER clinical research study is to determine the safety and efficacy of an investigational medication in children and young adults with newly diagnosed type 1 diabetes. The investigational medication is being tested to find out if it can maintain beta cell (insulin-producing) function in the pancreas of those newly diagnosed with type 1 diabetes.

    For study center locations and more information see:
  2. joshualevy

    joshualevy Approved members

    Dec 30, 2008

Share This Page


  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.
    Dismiss Notice